Journal of Clinical Pathways March 31, 2022
J Clin Pathways. 2022;8(2):24-25. doi:10.25270/jcp.2022.03.1
Clinical pathway developers need to be aware of a growing dominant user of resources—Medicare managed care. In the next year, it is highly likely that Medicare managed care will represent over half of the Medicare market and, as such, become a leader not only for Medicare care but also a guide for the Medicaid and commercial markets. Due to this situation, it is important to have an appreciation of where Medicare managed care is going.
The importance of Medicare managed care is illustrated by the announcement that Humana is spending $1 billion to fund growth and investment in its Medicare Advantage business. Human and United Healthcare own more than half of the Medicare Advantage (MA),...
Today's Sponsors
Today's Sponsor